Human immunodeficiency virus type 1 (HIV-1) infection in pediatric patients from Mexico
Vázquez-Rosales, J.é G.; Solórzano-Santos, F.; Alvarez-Muñoz, M.T.; Sanchez-Huerta, G.; Miranda-Novales, M.G.
Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 56(2): 153-168
2004
ISSN/ISBN: 0034-8376 PMID: 15377069 Document Number: 569691
Document emailed within 1 workday
Related Documents
Machado, A.A.; Hirsch, I.; Figueiredo, J.F.; Martinez, R.; de Freitas-Silva, G.; Chermann, J.C.; Covas, D.T. 1996: Occurrence of false positives in tests with synthetic peptides for the analysis of antibodies against the human immunodeficiency virus type 2 (HIV-2) in Brazilian patients infected with the human immunodeficiency virus type 1 (HIV-1) Revista da Sociedade Brasileira de Medicina Tropical 29(6): 615-617Kline, M.W.; Lewis, D.E.; Hollinger, F.B.; Reuben, J.M.; Hanson, L.C.; Kozinetz, C.A.; Dimitrov, D.H.; Rosenblatt, H.M.; Shearer, W.T. 1994: A comparative study of human immunodeficiency virus culture, polymerase chain reaction and anti-human immunodeficiency virus immunoglobulin A antibody detection in the diagnosis during early infancy of vertically acquired human immunodeficiency virus infection Pediatric Infectious Disease Journal 13(2): 90-94
Khasnis, A.A.; Karnad, D.R. 2003: Human immunodeficiency virus type 1 infection in patients with severe falciparum malaria in urban India Journal of Postgraduate Medicine 49(2): 114-117
Nagot, N.; Ouedraogo, A.; Konate, I.; Weiss, H.A.; Foulongne, V.; Defer, M.C.; Sanon, A.; Becquart, P.; Segondy, M.; Sawadogo, A.; Van de Perre, P.; Mayaud, P.; Bahembera, E.; Berthe, A.; Coulibaly, M.; Defer, M.-C.; Diallo, R.; Djagbare, D.; Konate, I.; Ky-Dama, F.; M'Boutiki, G.T.; Meda, N.; Millogo, I.; Ouedraogo, A.; Ouedraogo, D.; Rouet, F.ço.; Sanon, A.; Sawadogo, H.; Vallo, R.; Andonaba, J.-B.; Sawadogo, A.; Mayaud, P.; Weiss, H.A.; Nagot, N.; Becquart, P.; Foulongne, V.; Segondy, M.; Van de Perre, P. 2008: Roles of clinical and subclinical reactivated herpes simplex virus type 2 infection and human immunodeficiency virus type 1 (HIV-1)-induced immunosuppression on genital and plasma HIV-1 levels Journal of Infectious Diseases 198(2): 241-249
Del Olmo, J.A.; Añón, C.; Llovet, F.; Serra, M.A.; Wassel, A.; Rodrigo, J.M. 1995: Comparative study of the prevalence of hepatitis B virus infection and human immunodeficiency virus type 1 infection in the prison population between 1985 and 1992 Gastroenterologia y Hepatologia 18(8): 405-409
Kidangazhiayathmana, A. 2011: Is Kerala remaining low prevalent in human immunodeficiency virus by accident? a study of risk factors in acquiring human immunodeficiency virus infection in patients attending Anti-retroviral treatment clinic Indian Journal of Dermatology Venereology and Leprology 77(6): 729
Monteiro, J.P.; Freimanis-Hance, L.; Faria, L.B.; Mussi-Pinhata, M.M.; Korelitz, J.; Vannucchi, H.él.; Queiroz, W.; Succi, R.C.M.; Hazra, R. 2009: Both human immunodeficiency virus-infected and human immunodeficiency virus-exposed, uninfected children living in Brazil, Argentina, and Mexico have similar rates of low concentrations of retinol, beta-carotene, and vitamin e Nutrition Research 29(10): 716-722
1991: Human immunodeficiency virus type 1 infection of human placenta: potential route for fetal infection Disease Markers 9(6): 348
Wu, E. 1990: Pediatric infection caused by human acquired immunodeficiency virus Revista Chilena de Pediatria 61(Suppl 3): 1-3
Devare, S.G.; Desai, S.M.; Rupprecht, K.R.; Allen, R.G.; Dawson, G.J.; Hunt, J.C.; Casey, J.M. 1988: Genes of human immunodeficiency virus, type i (HIV-I), their expression in Escherichia coli, and their utility in diagnosis of virus infection Indian Journal of Biochemistry and Biophysics 25(6): 504-509
Coplan, P.M.; Gortmaker, S.; Hernandez-Avila, M.; Spiegelman, D.; Uribe-Zuñiga, P.; Mueller, N.E. 1996: Human immunodeficiency virus infection in Mexico City. Rectal bleeding and anal warts as risk factors among men reporting sex with men American Journal of Epidemiology 144(9): 817-827
Clarke, L.M.; Sierra, M.F.; Shahabbudin, M.; Cummings, R.V.; Pellegrino, M.G.; Steiner, P.; Volsky, D.J.; Nowakowski, M. 1992: Markers of human immunodeficiency virus infection in pediatric bronchoalveolar lavage samples Annals of Clinical and Laboratory Science 22(5): 290-299
Selimova, L.M.; Kalnina, L.B.; Serebrovskaya, L.V.; Ivanova, L.A.; Gulyaeva, A.N.; Nosik, D.N. 2016: Cytokines during the Human Immunodeficiency Virus Infection type 1(Hiv-1) Voprosy Virusologii 61(1): 39-41
Balzarini, J.; Velazquez, S.; San-Felix, A.; Karlsson, A.; Perez-Perez, M.J.; Camarasa, M.J.; De Clercq, E. 1993: Human immunodeficiency virus type 1-specific [2',5'-bis-O-(tert- butyldimethylsilyl)-beta-D-ribofuranosyl]-3'-spiro-5"-(4"-amino-1",2"- oxathiole-2",2"-dioxide)-purine analogues show a resistance spectrum that is different from that of the human immunodeficiency virus type 1-specific non-nucleoside analogues Molecular Pharmacology 43(1): 109-114
Yusim, K.; Peeters, M.; Pybus, O.G.; Bhattacharya, T.; Delaporte, E.; Mulanga, C.; Muldoon, M.; Theiler, J.; Korber, B. 2001: Using human immunodeficiency virus type 1 sequences to infer historical features of the acquired immune deficiency syndrome epidemic and human immunodeficiency virus evolution Philosophical Transactions of the Royal Society of London. Series B Biological Sciences 356(1410): 855-866
Horsburgh, C.R.; Holmberg, S.D. 1988: The global distribution of human immunodeficiency virus type 2 (HIV-2) infection Transfusion 28(2): 192-195
Emery, S.; Cooper, D.A. 1995: Antiretroviral therapy of human immunodeficiency virus type-1 (HIV-1) infection Australian and New Zealand Journal of Medicine 25(4): 344-349
Mancino, G.; Placido, R.; Bach, S.; Mariani, F.; Montesano, C.; Ercoli, L.; Zembala, M.; Colizzi, V. 1997: Infection of human monocytes with Mycobacterium tuberculosis enhances human immunodeficiency virus type 1 replication and transmission to T cells Journal of Infectious Diseases 175(6): 1531-1535
Hollak, C.E.; Kersten, M.J.; van der Lelie, J.; Lange, J.M. 1990: Thrombocytopenic purpura as first manifestation of human immunodeficiency virus type I (HIV-1) infection Netherlands Journal of Medicine 37(1-2): 63-68
Dunkle, L.M. 1995: Long-term survivors of human immunodeficiency virus type 1 infection New England Journal of Medicine 332(24): 1647; Author Reply 1647-1648